Functional Beta Cell Mass from Device-Encapsulated hESC-Derived Pancreatic Endoderm Achieving Metabolic Control
Open Access
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Stem Cell Reports
- Vol. 10 (3) , 739-750
Abstract
No abstract availableKeywords
Funding Information
- California Institute for Regenerative Medicine (DR1-01423)
- European Commission (FP7 241883)
- European Commission (H2020 681070)
- Juvenile Diabetes Research Foundation International (17-2013-296)
- Vlaamse regering (IWT130138)
- Juvenile Diabetes Research Foundation Australia
- Janssen Research and Development
This publication has 30 references indexed in Scilit:
- Inactivation of specific β cell transcription factors in type 2 diabetesJournal of Clinical Investigation, 2013
- A Scalable System for Production of Functional Pancreatic Progenitors from Human Embryonic Stem CellsPLOS ONE, 2012
- Rat neonatal beta cells lack the specialised metabolic phenotype of mature beta cellsDiabetologia, 2011
- Cell cycle control of β-cell replication in the prenatal and postnatal human pancreasAmerican Journal of Physiology-Endocrinology and Metabolism, 2011
- Simultaneous Measurement of Plasma Concentrations of Proinsulin and C-Peptide and Their Ratio with a Trefoil-Type Time-Resolved Fluorescence ImmunoassayClinical Chemistry, 2008
- Restoring a functional β‐cell mass in diabetesDiabetes, Obesity and Metabolism, 2008
- Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivoNature Biotechnology, 2008
- Correlation between β cell mass and glycemic control in type 1 diabetic recipients of islet cell graftProceedings of the National Academy of Sciences, 2006
- Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cellsNature Biotechnology, 2006
- Prolonged exposure of human beta cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation.Journal of Clinical Investigation, 1996